These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 16885549)

  • 21. Compound heterozygous mutations in the SUR1 (ABCC 8) subunit of pancreatic K(ATP) channels cause neonatal diabetes by perturbing the coupling between Kir6.2 and SUR1 subunits.
    Lin YW; Akrouh A; Hsu Y; Hughes N; Nichols CG; De León DD
    Channels (Austin); 2012; 6(2):133-8. PubMed ID: 22562119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children.
    Jahnavi S; Poovazhagi V; Mohan V; Bodhini D; Raghupathy P; Amutha A; Suresh Kumar P; Adhikari P; Shriraam M; Kaur T; Das AK; Molnes J; Njolstad PR; Unnikrishnan R; Radha V
    Clin Genet; 2013 May; 83(5):439-45. PubMed ID: 22831748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of KATP hyperactivity and sulfonylurea tolerance due to a diabetogenic mutation in L0 helix of sulfonylurea receptor 1 (ABCC8).
    Babenko AP; Vaxillaire M
    FEBS Lett; 2011 Nov; 585(22):3555-9. PubMed ID: 22020219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes in very young children and mutations in the insulin-secreting cell potassium channel genes: therapeutic consequences.
    Flechtner I; Vaxillaire M; Cavé H; Scharfmann R; Froguel P; Polak M
    Endocr Dev; 2007; 12():86-98. PubMed ID: 17923772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Permanent neonatal diabetes with known genetic background: oral drugs in treatment of childhood diabetes].
    Gach A; Gadzicka A; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2008; 14(1):45-9. PubMed ID: 18577347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.
    Stanik J; Gasperikova D; Paskova M; Barak L; Javorkova J; Jancova E; Ciljakova M; Hlava P; Michalek J; Flanagan SE; Pearson E; Hattersley AT; Ellard S; Klimes I
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1276-82. PubMed ID: 17213273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
    Masia R; Enkvetchakul D; Nichols CG
    J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tolbutamide site of SUR1 and a mechanism for its functional coupling to K(ATP) channel closure.
    Babenko AP; Gonzalez G; Bryan J
    FEBS Lett; 1999 Oct; 459(3):367-76. PubMed ID: 10526167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional characterization of activating mutations in the sulfonylurea receptor 1 (ABCC8) causing neonatal diabetes mellitus in Asian Indian children.
    Balamurugan K; Kavitha B; Yang Z; Mohan V; Radha V; Shyng SL
    Pediatr Diabetes; 2019 Jun; 20(4):397-407. PubMed ID: 30861254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
    Tammaro P; Ashcroft F
    J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism.
    Gloyn AL; Siddiqui J; Ellard S
    Hum Mutat; 2006 Mar; 27(3):220-31. PubMed ID: 16416420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
    Girard CA; Shimomura K; Proks P; Absalom N; Castano L; Perez de Nanclares G; Ashcroft FM
    Pflugers Arch; 2006 Dec; 453(3):323-32. PubMed ID: 17021801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels.
    Tammaro P; Proks P; Ashcroft FM
    J Physiol; 2006 Feb; 571(Pt 1):3-14. PubMed ID: 16339180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.
    Flanagan SE; Clauin S; Bellanné-Chantelot C; de Lonlay P; Harries LW; Gloyn AL; Ellard S
    Hum Mutat; 2009 Feb; 30(2):170-80. PubMed ID: 18767144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two neonatal diabetes mutations on transmembrane helix 15 of SUR1 increase affinity for ATP and ADP at nucleotide binding domain 2.
    Ortiz D; Voyvodic P; Gossack L; Quast U; Bryan J
    J Biol Chem; 2012 May; 287(22):17985-95. PubMed ID: 22451668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotypes of the pancreatic beta-cell K-ATP channel and clinical phenotypes of Japanese patients with persistent hyperinsulinaemic hypoglycaemia of infancy.
    Ohkubo K; Nagashima M; Naito Y; Taguchi T; Suita S; Okamoto N; Fujinaga H; Tsumura K; Kikuchi K; Ono J
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):458-65. PubMed ID: 15807877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
    Proks P; Antcliff JF; Lippiat J; Gloyn AL; Hattersley AT; Ashcroft FM
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17539-44. PubMed ID: 15583126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.
    Craig TJ; Shimomura K; Holl RW; Flanagan SE; Ellard S; Ashcroft FM
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2551-7. PubMed ID: 19351728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype.
    Klupa T; Kowalska I; Wyka K; Skupien J; Patch AM; Flanagan SE; Noczynska A; Arciszewska M; Ellard S; Hattersley AT; Sieradzki J; Mlynarski W; Malecki MT
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):358-62. PubMed ID: 19021632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
    Gloyn AL; Pearson ER; Antcliff JF; Proks P; Bruining GJ; Slingerland AS; Howard N; Srinivasan S; Silva JM; Molnes J; Edghill EL; Frayling TM; Temple IK; Mackay D; Shield JP; Sumnik Z; van Rhijn A; Wales JK; Clark P; Gorman S; Aisenberg J; Ellard S; Njølstad PR; Ashcroft FM; Hattersley AT
    N Engl J Med; 2004 Apr; 350(18):1838-49. PubMed ID: 15115830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.